-
Company Insights
NewElevance Health – Digital Transformation Strategies
Elevance Health Digital Transformation Strategies Overview Elevance Health is tapping the power of big data analytics to analyze data and generate insights, improve member engagement, and detect fraudulent claims. AI, big data, cloud, and automation are among the key technologies under focus for the company. The annual ICT spending of Elevance Health was estimated at $3.8 billion in 2023. A major share of this spending is earmarked for acquiring software, network and communications, and hardware from vendors. Elevance Health Inc...
-
Innovation Ranking
NewInnovation Ranking – Hyundai Elevator Co Ltd
Hyundai Elevator Co Ltd (Hyundai Elevator) carries out the business of producing a range of vertical and horizontal transportation systems. It offers products such as elevators, marine elevators, escalators, and parking systems. The company's elevators range includes passenger elevators, observation elevators, hospital elevators, automobile elevators and freight elevators. Hyundai Elevator also provides Hyundai Integrated Parking (HIP) system, cart type parking system. It offers services such as Hyundai Real Time Services (HRTS), maintenance, installation services and Hyundai Customer Care Center (HCCC)....
-
Product Insights
NewLikelihood of Approval Analysis for Acute Coronary Syndrome
Overview How likely is it that the drugs in Acute Coronary Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Coronary Syndrome Overview Acute coronary syndrome (ACS) encompasses ST-elevation myocardial...
-
Product Insights
NewLikelihood of Approval Analysis for Hyperphenylalaninemia
Overview How likely is it that the drugs in Hyperphenylalaninemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hyperphenylalaninemia Overview Abnormally elevated levels of phenylalanine (PHE) in the blood if >2mg/dl...
-
Product Insights
NewLikelihood of Approval Analysis for Polymyalgia Rheumatica (PMR)
Overview How likely is it that the drugs in Polymyalgia Rheumatica (PMR) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polymyalgia Rheumatica (PMR) Overview Polymyalgia rheumatica (PMR) is a rheumatic disorder...
-
Product Insights
NewLikelihood of Approval Analysis for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Overview How likely is it that the drugs in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Overview Waldenstrom macroglobulinemia, one of the...
-
Product Insights
NewLikelihood of Approval Analysis for Hypereosinophilic Syndrome
Overview How likely is it that the drugs in Hypereosinophilic Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypereosinophilic Syndrome Overview Hypereosinophilic syndrome (HES) is a disease characterized by a...
-
Product Insights
NewLikelihood of Approval Analysis for Tetanus
Overview How likely is it that the drugs in Tetanus will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tetanus Overview Tetanus is a serious illness caused by Clostridium bacteria. Signs and...
-
Product Insights
Elevation Solar PV Park
Elevation Solar PV Park is a solar PV project located in California, United States. The project is owned by Alberta Investment Management Corp; StepStone Group LP; The AES Corp; ULLICO Inc and was developed by Sustainable Power Group LLC. The project came online in 2016. Empower your strategies with our Elevation Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3...
-
Product Insights
NewLikelihood of Approval Analysis for Dyslipidemia
Overview How likely is it that the drugs in Dyslipidemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dyslipidemia Overview Dyslipidemia is defined as elevation of the total cholesterol, the "bad"...